Asthma control and treatment steps in Turkish children with Asthma during the COVID-19 pandemic

Main Article Content

Özge Atay
Suna Asilsoy
Seda Şirin Köse
Gizem Atakul
Serdal Al
Özge Kangallı Boyacıoğlu
Nevin Uzuner


Objective: Since viral infections are one of the most important factors affecting asthma control, various precautions and recommendations for asthma patients came to the fore at the beginning of the COVID-19 pandemic. In our study, we aimed to evaluate the effects of the COVID-19 pandemic on asthma control and treatment steps of children with asthma.

Materials and Methods: The date of March 11, 2019, was accepted as the beginning of the pandemic. The application deadline to our outpatient clinic of patients within one year after the onset of the pandemic (AOP) was determined. After that, the period of the same season before the beginning of the pandemic (BOP) was determined. We recorded the asthma treatment steps, asthma control test (ACT) scores, and the number of applications to our outpatient clinic during the BOP and AOP periods of the patients.

Results: In our study, 384 patients, 64.8% of whom were male, with a median age of 11 years, were evaluated. SARS-CoV-2 PCR positivity was detected in 6 (1.6%) patients. BOP, patient treatment steps, and the number of outpatient clinic applications were higher (p <0.001). AOP, there was no significant change in ACT scores (p = 0.059). Whereas asthma control was worse in patients susceptible to house dust mite (p = 0.01).

Conclusions: Although measures such as home quarantine and mask use have been reported to have positive effects on asthma control, increased exposure to house dust mites in susceptible patients may pose a risk of uncontrolled asthma.


Download data is not yet available.

Article Details

How to Cite
Atay, Özge, Asilsoy, S., Köse, S. Şirin, Atakul, G., Al, S., Boyacıoğlu, Özge K., & Uzuner, N. (2022). Asthma control and treatment steps in Turkish children with Asthma during the COVID-19 pandemic . Medical Science and Discovery, 9(4), 220–227.
Research Article
Received 2022-03-15
Accepted 2022-04-07
Published 2022-04-08


Wang Y, Chen J, Chen W, Liu L, Dong M, Ji J, et al. Does Asthma Increase the Mortality of Patients with COVID-19?: A Systematic Review and Meta-Analysis. Int Arch Allergy Immunol. 2021;182(1):76-82. doi: 10.1159/000510953. Epub 2020 September 22. PMID: 32961539; PMCID: PMC7573909.

WHO Director-General’s opening remarks at the media briefing on COVID-19 - March 11, 2020. Available from:

Republic of Turkey Ministry of Health. COVID-19 information page. [Internet]. [Cited: 2021 MARCH 11]. Available from:

Serebrisky D, Wiznia A. Pediatric Asthma: A Global Epidemic. Ann Glob Health. 2019;22;85(1):6. doi: 10.5334/aogh.2416. PMID: 30741507; PMCID: PMC7052318.

Global Initiuative for Asthma. Global strategy for asthma management and prevention: Revised asthma guidelines 2020 [Internet]. 2020 [cited 2020 Mar 19]. Available from:

Abadoğlu Ö, Aydın Ö, Bavbek S, Büyüköztürk S, Çelik GE, Ediger D. Astım Tanı ve Tedavi Rehberi 2020 Güncellemesi. Ankara: BULUŞ Tasarım ve Matbaacılık Hizmetleri San. Tic2020, pp.343. Avaliable from:

National Asthma Education and Prevention Program. Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma – summary report 2007. J Allergy Clin Immunol. 2007; 120: Suppl. 5, S94–S138.

Dharmage SC, Perret JL, Custovic A. Epidemiology of Asthma in Children and Adults. Front Pediatr. 2019;18:7:246. doi: 10.3389/fped.2019.00246. PMID: 31275909; PMCID: PMC6591438.

Shaker MS, Oppenheimer J, Grayson M, Stukus D, Hartog N, Hsieh EWY, et al. COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic. J Allergy Clin Immunol Pract. 2020;8(5):1477-1488.e5. doi: 10.1016/j.jaip.2020.03.012. Epub 2020 March 26. PMID: 32224232; PMCID: PMC7195089.

Abrams EM, Szefler SJ. Managing Asthma during Coronavirus Disease-2019: An Example for Other Chronic Conditions in Children and Adolescents. J Pediatr. 2020;222:221-226. doi: 10.1016/j.jpeds.2020.04.049. Epub 2020 April 21. PMID: 32330469; PMCID: PMC7172836.

Tu YL, Chang SW, Tsai HJ, Chen LC, Lee WI, Hua MC, et al.; PATCH study group. Total serum IgE in a population-based study of Asian children in Taiwan: reference value and significance in the diagnosis of allergy. PLoS One. 2013;8(11):e80996. doi: 10.1371/journal.pone.0080996. PMID: 24278361; PMCID: PMC3835572.

Fulkerson PC, Rothenberg ME. Targeting eosinophils in allergy, inflammation and beyond. Nat Rev Drug Discov. 2013;12 (2): 117-29. doi: 10.1038/nrd3838. Epub 2013 January 21. PMID: 23334207; PMCID: PMC3822762.

Uysal MA, Mungan D, Yorgancioglu A, Yildiz F, Akgun M, Gemicioglu B, et al; Turkish Asthma Control Test (TACT) Study Group. The validation of the Turkish version of Asthma Control Test. Qual Life Res. 2013; 22 (7): 1773-9. doi: 10.1007/s11136-012-0309-1. Epub 2012 Nov 10. Erratum in: Qual Life Res. 2013; 22 (7): 1781-2. Uysal, Mehmet Atilla [added]; Mungan, Dilsad [added]; Yorgancioglu, Arzu [added]; Yildiz, Fusun [added]; Akgun, Metin [added]; Gemicioglu, Bilun [added]; Turktas, Haluk [added]. PMID: 23143589.

Turkish version of Asthma Control Test. Available from

Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc 2011; 86: 304-14.

Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-1242. doi: 10.1001/jama.2020.2648. PMID: 32091533.

Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020; 75 (7): 1730-1741. doi: 10.1111/all.14238. Epub 2020 February 27. PMID: 32077115.

Rabha AC, Oliveira Junior FI, Oliveira TA, Cesar RG, Fongaro G, Mariano RF, et al. CLINICAL MANIFESTATIONS OF CHILDREN AND ADOLESCENTS WITH COVID-19: REPORT OF THE FIRST 115 CASES FROM SABARÁ HOSPITAL INFANTIL. Rev Paul Pediatr. 2020;39:e2020305. doi: 10.1590/1984-0462/2021/39/2020305. PMID: 33263697; PMCID: PMC7695045.

Du H, Dong X, Zhang JJ, Cao YY, Akdis M, Huang PQ, et al. Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status. Allergy. 2021;76(2):510-532. doi: 10.1111/all.14452. Epub 2020 September 3. PMID: 32524611; PMCID: PMC7307120.

Şık N, Özlü C, Karaoğlu Asrak H, Erbaş İC, Çakıl Güzin A, Atakul G, et al. Çocuk Acil Serviste SARS-CoV-2 PCR Pozitif Saptanan Olguların Değerlendirilmesi [Evaluation of SARS-CoV-2 PCR Positive Cases in the Pediatric Emergency Department]. Mikrobiyol Bul. 2020 Oct;54(4):629-637. Turkish. doi: 10.5578/mb.70086. PMID: 33107292.

Carli G, Cecchi L, Stebbing J, Parronchi P, Farsi A. Is asthma protective against Covid-19? Allergy 2020 June 17: doi: 10.1111/all.14426.

Ferastraoaru D, Hudes G, Jerschow E, Jariwala S, Karagic M, de Vos G, et al. Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness. J Allergy Clin Immunol Pract. 2021;9(3):1152-1162.e3. doi: 10.1016/j.jaip.2020.12.045. Epub 2021 January 23. PMID: 33495097; PMCID: PMC7826039.

Gupta A, Bush A, Nagakumar P. Asthma in children during the COVID-19 pandemic: lessons from lockdown and future directions for management. Lancet Respir Med. 2020;8(11):1070-1071. doi: 10.1016/S2213-2600(20)30278-2. Epub 2020 June 25. PMID: 32593314; PMCID: PMC7316451.

Ozturk AB, Baççıoğlu A, Soyer O, Civelek E, Şekerel BE, Bavbek S. Change in Allergy Practice during the COVID-19 Pandemic. Int Arch Allergy Immunol. 2021;182(1):49-52. doi: 10.1159/000512079. Epub 2020 October 15. PMID: 33059353; PMCID: PMC7649687.

Papadopoulos NG, Custovic A, Deschildre A, Mathioudakis AG, Phipatanakul W, Wong G, et al. Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden. J Allergy Clin Immunol Pract. 2020;8(8):2592-2599.e3. doi: 10.1016/j.jaip.2020.06.001. Epub 2020 June 17. PMID: 32561497; PMCID: PMC7297686.

Kenyon CC, Hill DA, Henrickson SE, Bryant-Stephens TC, Zorc JJ. Initial effects of the COVID-19 pandemic on pediatric asthma emergency department utilization. J Allergy Clin Immunol Pract. 2020;8(8):2774-2776.e1. doi: 10.1016/j.jaip.2020.05.045. Epub 2020 June 6. PMID: 32522565; PMCID: PMC7483361.

Oreskovic NM, Kinane TB, Aryee E, Kuhlthau KA, Perrin JM. The Unexpected Risks of COVID-19 on Asthma Control in Children. J Allergy Clin Immunol Pract. 2020;8(8):2489-2491. doi: 10.1016/j.jaip.2020.05.027. Epub 2020 June 1. PMID: 32497662; PMCID: PMC7263244.

Pijnenburg MW, Baraldi E, Brand PL, Carlsen KH, Eber E, Frischer T, et al. Monitoring asthma in children. Eur Respir J. 2015;45(4):906-25. doi: 10.1183/09031936.00088814. Epub 2015 Mar 5. PMID: 25745042.

Yucel E, Suleyman A, Hizli Demirkale Z, Guler N, Tamay ZU, Ozdemir C. 'Stay at home': Is it good or not for house dust mite sensitized children with respiratory allergies? [published online ahead of print, 2021 February 18]. Pediatr Allergy Immunol. 2021;10.1111/pai.13477. doi:10.1111/pai.13477